Electromed, Inc. (NYSEAMERICAN:ELMD – Get Rating) shares passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.00 and traded as high as $10.65. Electromed shares last traded at $10.65, with a volume of 3,103 shares changing hands.
Several analysts recently issued reports on the company. Colliers Securities reiterated a “buy” rating on shares of Electromed in a report on Tuesday, March 22nd. TheStreet lowered Electromed from a “b” rating to a “c+” rating in a report on Thursday, April 14th.
The firm has a market cap of $91.82 million, a price-to-earnings ratio of 43.04, a PEG ratio of 4.16 and a beta of 0.65.
Hedge funds have recently added to or reduced their stakes in the stock. Riverwater Partners LLC acquired a new stake in Electromed during the fourth quarter worth about $256,000. Two Sigma Advisers LP grew its position in Electromed by 4.4% during the third quarter. Two Sigma Advisers LP now owns 40,000 shares of the medical equipment provider’s stock worth $433,000 after buying an additional 1,694 shares in the last quarter. Franklin Resources Inc. acquired a new stake in Electromed during the third quarter worth about $335,000. Man Group plc grew its position in Electromed by 99.0% during the third quarter. Man Group plc now owns 23,262 shares of the medical equipment provider’s stock worth $252,000 after buying an additional 11,572 shares in the last quarter. Finally, Annex Advisory Services LLC acquired a new stake in Electromed during the fourth quarter worth about $206,000. 39.67% of the stock is currently owned by institutional investors and hedge funds.
About Electromed (NYSEAMERICAN:ELMD)
Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.
- Get a free copy of the StockNews.com research report on Electromed (ELMD)
- Lithium Stocks Are Offering Unprecedented Opportunity To Investors
- Here’s Why Boeing (NYSE: BA) Is Worth The Risk
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.